Drug
Placebo Dose 1
Placebo Dose 1 is a pharmaceutical drug with 3 clinical trials. Historical success rate of 100.0%.
Total Trials
3
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 3 completed trials
Completion Rate
100%(3/3)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
Ph phase_2
3
100%
Phase Distribution
0
Early Stage
3
Mid Stage
0
Late Stage
Phase Distribution3 total trials
Phase 2Efficacy & side effects
3(100.0%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
100.0%
3 of 3 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
3
all time
Status Distribution
Completed(3)
Detailed Status
Completed3
Development Timeline
Analytics
Development Status
Total Trials
3
Active
0
Success Rate
100.0%
Most Advanced
Phase 2
Trials by Phase
Phase 23 (100.0%)
Trials by Status
completed3100%
Recent Activity
0 active trials
Showing 3 of 3
completedphase_2
A Clinical Study to Assess the Efficacy and Safety of SED80 for Use in Cataract Surgery
NCT04711213
completedphase_2
Study of the Efficacy and Safety of SCH 486757 in Subjects With Chronic Cough (Study P04887)
NCT00506987
completedphase_2
Study of the Efficacy and Safety of SCH 619734 in Subjects With Chronic Cough From an Unknown Cause (Study P04888)
NCT00506545
Clinical Trials (3)
Showing 3 of 3 trials
NCT04711213Phase 2
A Clinical Study to Assess the Efficacy and Safety of SED80 for Use in Cataract Surgery
NCT00506987Phase 2
Study of the Efficacy and Safety of SCH 486757 in Subjects With Chronic Cough (Study P04887)
NCT00506545Phase 2
Study of the Efficacy and Safety of SCH 619734 in Subjects With Chronic Cough From an Unknown Cause (Study P04888)
All 3 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 3